Identification of pathways modulating vemurafenib resistance in melanoma cells via a genome-wide CRISPR/Cas9 screen.

MLA

Goh, Corinna Jie Hui, et al. “Identification of Pathways Modulating Vemurafenib Resistance in Melanoma Cells via a Genome-Wide CRISPR/Cas9 Screen.” G3 (Bethesda, Md.), vol. 11, no. 2, Feb. 2021. EBSCOhost, https://doi.org/10.1093/g3journal/jkaa069.

APA

Goh, C. J. H., Wong, J. H., El Farran, C., Tan, B. X., Coffill, C. R., Loh, Y.-H., Lane, D., & Arumugam, P. (2021). Identification of pathways modulating vemurafenib resistance in melanoma cells via a genome-wide CRISPR/Cas9 screen. G3 (Bethesda, Md.), 11(2). https://doi.org/10.1093/g3journal/jkaa069

Chicago

Goh, Corinna Jie Hui, Jin Huei Wong, Chadi El Farran, Ban Xiong Tan, Cynthia R Coffill, Yuin-Hain Loh, David Lane, and Prakash Arumugam. 2021. “Identification of Pathways Modulating Vemurafenib Resistance in Melanoma Cells via a Genome-Wide CRISPR/Cas9 Screen.” G3 (Bethesda, Md.) 11 (2). doi:10.1093/g3journal/jkaa069.